Press Releases
Back to Previous Page
 


News Release
December 19, 2016
Your Contact:
Karen Tiano +1 978-495-0093



MilliporeSigma Announces Winner of Life Science Award in Bioseparations
  • Ying Li, from The Pennsylvania State University named winner
  • Award recognizes cutting-edge bioseparations research

Billerica, Massachusetts, December 19, 2016 MilliporeSigma today announced that Ying Li, from The Pennsylvania State University, has won the company’s Life Science Award in Bioseparations. The award was open to students from U.S. or Canadian universities who are working on cutting-edge bioseparations research, and who show potential to be future leaders in the field.

Li was recognized for her research on novel strategies to control membrane fouling and enhance performance during ultrafiltration of plasmid DNA, and received the top prize of $10,000.

“MilliporeSigma recognizes that the academic community is the foundation and future of life science,” said Udit Batra, Member of the Executive Board of Merck KGaA, Darmstadt, Germany and CEO, MilliporeSigma. “It is our goal to support and reward upcoming leaders of our industry and establish opportunities to connect and collaborate, so that together we can develop impactful advancements in bioseparations research.”

Entries were judged on level of innovation, impact to industry, and scientific rigor and communication. Three finalists were also recognized and each received $1,500. They are:

Daniel Greene, University of Delaware
Characterization of precipitate microstructures formed during protein purification

Rudra Mukherjee, University of Arkansas
Recombinant platform for production and purification of a novel anti-Candida peptide

Rahul Sadavarte, McMaster University
Analytical laterally-fed membrane chromatography for rapid detection of monoclonal antibody oxidation

This is the second year the competition has been held in the U.S. and Canada.  A similar award program is offered in Europe.

About the Life Science Business of Merck KGaA, Darmstadt, Germany
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 19,000 employees and 65 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery. Udit Batra is the global chief executive officer of MilliporeSigma.

Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $125 billion global life science industry.

Merck KGaA of Darmstadt, Germany is a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials. The company has six businesses – Biopharmaceuticals, Consumer Health, Allergopharma, Biosimilars, Life Science and Performance Materials – and generated sales of €12.85 billion in 2015. Around 50,000 employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges.

Merck KGaA, Darmstadt, Germany is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. The company holds the global rights to the name and the trademark “Merck” internationally except for the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.